GlobeNewswire

World’s #1 Selling Contact Lens Brand ACUVUE®*1 Brings Pioneering Innovation For Astigmatic Patients With Presbyopia, Providing Visual Clarity And Comfort**2…

Jabra’s new PanaCast 55 VBS, PanaCast SpeakerMic and PanaCast Room Kits create a new portfolio of expandable room solutions that…

PINEHURST. N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) — How does sleepwear influence sleep hygiene? That question is explored by Tanda…

SHERWOOD, Wis., Feb. 03, 2026 (GLOBE NEWSWIRE) — How much should homeowners in the Fox Cities budget for a kitchen…

SHANGHAI, Feb. 03, 2026 (GLOBE NEWSWIRE) — CYCJET, a leading global manufacturer of industrial inkjet marking and coding solutions, has…

LEADING EDGE MATERIALS’ PROGRESS UPDATE ON ROMANIAN EXPLORATION PROJECT 2025 exploration campaign identifies significant areas of mineralisation underground in Valea…

HemostOD awarded CHF 2 million Innosuisse grant to support key development milestones Lausanne, Switzerland — 03 February 2026 – HemostOD,…

In January 2026, AS Tallink Grupp transported 337,926 passengers, which is a 12.6% increase compared to January 2025. The number…

3 February 2026 News Release   Pharma Equity Group2026 Financial Calendar   ​March 4 Deadline for shareholder proposals – Annual…

Disclosure of trading in own shares occurred from January 26 to January 30, 2026 Puteaux, February 3, 2026 In accordance…

First publication of clinical efficacy data for PP353, in development for chronic Low Back Pain Trial demonstrated that PP353 delivers…

Daring Cryptocurrency Prop Firm Secures Strategic Investment to Expand Trading Capital and Opportunities for Qualified Traders. NEW YORK, Feb. 03,…

WEBSTER, N.Y., Feb. 03, 2026 (GLOBE NEWSWIRE) — When should parents start thinking about orthodontic care for their children? That…

WINTER HAVEN, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) — What should homeowners prioritize to maximize both price and efficiency when…

Highlights advancing clinical-stage pipeline, including two major value-creating programs for primary immunodeficiencies (PIDs) with immune dysregulation and mtDNA-driven mitochondrial disease…